---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-024444"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2022-08-31T23:59:59+00:00"
generated_at: "2026-06-23T18:33:19.256106+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical closes $6.75M first tranche of private placement; appoints Vizirgianakis Chairman

## Summary
- First tranche: sold 14.1M shares and warrants for 3.5M shares at ~$6.75M to accredited investors.
- Second tranche of ~$3.0M (6.2M shares + 1.6M warrants) expected early October 2022.
- Board expanded to 7 directors; Stavros Vizirgianakis elected Chairman, replacing Jeffrey Peters.
- 2022 Annual Meeting set for October 26, 2022; proxy materials to be mailed around September 20.
- Net proceeds to support working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-22-024444
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2022-08-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 5.02, 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-024444
- JSON: https://secwatch.observer/filing/0001493152-22-024444.json
- Plain text: https://secwatch.observer/filing/0001493152-22-024444.txt

## Key facts
- Executive change
  Stavros Vizirgianakis was appointed as Chairman of the Board at Xtant Medical Holdings, Inc..
  - Action: appointed
  - Role: Chairman of the Board
  source text: the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm
- Executive change
  Jeffrey Peters changed role as Chairman of the Board at Xtant Medical Holdings, Inc..
  - Action: replaced
  - Role: Chairman of the Board
  source text: the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.